Gamma-aminobutyric acid inhibits synergistic interleukin-6 release but not transcriptional activation in astrocytoma cells.
Gamma-aminobutyric acid inhibits synergistic interleukin-6 release but not transcriptional activation in astrocytoma cells.
复制标题
γ-氨基丁酸抑制星形细胞瘤细胞中白细胞介素 6 的协同释放,但不抑制转录激活。
DOI:
10.1159/000148194
复制
发表时间:
2008
影响因子:
2.4
通讯作者:
Spangelo,BryanL
中科院分区:
文献类型:
--
作者:
RoachJr,JosephD;Aguinaldo,GrantT;Jonnalagadda,Kaumudi;HughesJr,FrancisM;Spangelo,BryanL
Objective:A decline in the inhibitory neurotransmitter γ-aminobutyric acid (GABA) may enhance cytokine release in Alzheimer’s disease (AD) resulting in neuroinflammation. We investigated the GABA-mediated suppression of the synergistic release of interleukin (IL)-6 due to interleukin 1-β (IL-1β) and tumor necrosis factor-α (TNF-α).Methods:Rat C6 astrocytoma cells were treated with IL-1β and TNF-α in the absence and presence of GABA. Activation of p38, degradation of IĸB-α and total cellular IL-6 were determined by Western blot analysis. IL-6 release and gene expression were measured by ELISA and RT-PCR, respectively.Results:Although p38 and nuclear factor (NF)-ĸB are essential for the synergistic release of IL-6, GABA did not affect either p38 phosphorylation or IĸB-α degradation. Additionally, GABA suppressed IL-6 release but did not alter cytokine-driven synergistic increases in IL-6 gene expression. Western blot analysis revealed that co-treatments with IL-1β and TNF-α resulted in an increase in intracellular IL-6 that was prevented by GABA.Conclusion:GABA-induced inhibition of IL-6 release appears to coincide with a reduction in cellular IL-6. The GABA-induced suppression of IL-6 release may include inhibition of IL-6 gene translation.